Process View
The establishment of the sex of a female organism by physical differentiation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "female sex differentiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| INSR | insulin receptor | 0.530 | Fly | |
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.491 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.261 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.232 | Fly | |
| BCL2 | B-cell CLL/lymphoma 2 | 0.146 | Mouse Rat | |
| BCL2L1 | BCL2-like 1 | 0.136 | Mouse Rat | |
| NRP1 | neuropilin 1 | 0.129 | ||
| CREBBP | CREB binding protein | 0.122 | ||
| HNRNPD | heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) | 0.119 | ||
| DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 0.108 | ||
| TP53 | tumor protein p53 | 0.108 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.106 | ||
| ESR1 | estrogen receptor 1 | 0.103 | Mouse | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.094 | ||
| HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.078 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.076 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.067 | ||
| EGFR | epidermal growth factor receptor | 0.061 | ||
| PDX1 | pancreatic and duodenal homeobox 1 | 0.060 | ||
| HNRNPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) | 0.058 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.056 | ||
| CCND1 | cyclin D1 | 0.052 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.050 | ||
| PLAU | plasminogen activator, urokinase | 0.048 | ||
| IRS1 | insulin receptor substrate 1 | 0.047 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.045 | ||
| AP1M1 | adaptor-related protein complex 1, mu 1 subunit | 0.045 | ||
| FSTL1 | follistatin-like 1 | 0.043 | ||
| MPDZ | multiple PDZ domain protein | 0.039 | ||
| GAS6 | growth arrest-specific 6 | 0.038 | ||
| VEGFA | vascular endothelial growth factor A | 0.037 | Mouse | |
| ACTB | actin, beta | 0.036 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.036 | Mouse | |
| FGFR2 | fibroblast growth factor receptor 2 | 0.034 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.034 | ||
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.034 | ||
| GATA4 | GATA binding protein 4 | 0.033 | ||
| CCNE1 | cyclin E1 | 0.032 | Rat | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.030 | ||
| TARDBP | TAR DNA binding protein | 0.028 | ||
| PRKCA | protein kinase C, alpha | 0.028 | Fly | |
| TDGF1 | teratocarcinoma-derived growth factor 1 | 0.026 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.026 | ||
| IRS2 | insulin receptor substrate 2 | 0.024 | ||
| AXIN1 | axin 1 | 0.024 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.023 | ||
| RNR2 | l-rRNA | 0.023 | ||
| PLAT | plasminogen activator, tissue | 0.022 | ||
| NF2 | neurofibromin 2 (merlin) | 0.021 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.020 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.020 | ||
| SFN | stratifin | 0.019 | ||
| SP1 | Sp1 transcription factor | 0.019 | ||
| DVL1 | dishevelled, dsh homolog 1 (Drosophila) | 0.019 | Fly | |
| JDP2 | Jun dimerization protein 2 | 0.019 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.019 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.018 | ||
| KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.018 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.017 | ||
| INHBA | inhibin, beta A | 0.017 | ||
| HDAC6 | histone deacetylase 6 | 0.017 | ||
| TOP1 | topoisomerase (DNA) I | 0.017 | ||
| CHD8 | chromodomain helicase DNA binding protein 8 | 0.017 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.017 | ||
| PAX8 | paired box 8 | 0.017 | ||
| HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 0.017 | Fly | |
| HIPK2 | homeodomain interacting protein kinase 2 | 0.016 | ||
| TRRAP | transformation/transcription domain-associated protein | 0.015 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.015 | ||
| CCDC6 | coiled-coil domain containing 6 | 0.015 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.015 | ||
| PGF | placental growth factor | 0.015 | ||
| EP300 | E1A binding protein p300 | 0.015 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.015 | ||
| LAT | linker for activation of T cells | 0.014 | ||
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.014 | ||
| HNRNPH1 | heterogeneous nuclear ribonucleoprotein H1 (H) | 0.014 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.014 | ||
| CSNK1D | casein kinase 1, delta | 0.014 | ||
| GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.014 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.014 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.013 | ||
| RAI1 | retinoic acid induced 1 | 0.013 | ||
| FANCB | Fanconi anemia, complementation group B | 0.013 | ||
| ZNF512B | zinc finger protein 512B | 0.013 | ||
| BRCA2 | breast cancer 2, early onset | 0.013 | Mouse | |
| KITLG | KIT ligand | 0.012 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.012 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.012 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.012 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.012 | ||
| ARRB1 | arrestin, beta 1 | 0.012 | ||
| DMC1 | DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) | 0.012 | Mouse | |
| TMSB4X | thymosin beta 4, X-linked | 0.012 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.012 | ||
| GDF5 | growth differentiation factor 5 | 0.011 | ||
| NDP | Norrie disease (pseudoglioma) | 0.011 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.011 | ||
| HNRPDL | heterogeneous nuclear ribonucleoprotein D-like | 0.011 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.011 | ||
| RNF144B | ring finger protein 144B | 0.011 | ||
| PCGF2 | polycomb group ring finger 2 | 0.011 | ||
| CSNK1E | casein kinase 1, epsilon | 0.011 | ||
| VEGFC | vascular endothelial growth factor C | 0.011 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.011 | ||
| WT1 | Wilms tumor 1 | 0.011 | Mouse | |
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.010 | ||
| CPE | carboxypeptidase E | 0.010 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.010 |